Xuezhikang
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Xuezhikang, covering 2014-05-19 to 2025-04-03. Get the full timeline:
Most recent: Clinical Trial Update: The Effects of Xuezhikang and Atorvastatin on Lipid in Patients With Dyslipidemia and Prediabetes [Phase 4]